{"id":49504,"date":"2026-02-27T09:33:00","date_gmt":"2026-02-27T02:33:00","guid":{"rendered":"https:\/\/thaipropertynews.com\/feeds\/?p=49504"},"modified":"2026-02-27T09:33:00","modified_gmt":"2026-02-27T02:33:00","slug":"cynosure-lutronic-bolsters-its-strength-in-apac-the-worlds-fastest-growing-medical-aesthetics-device-region-with-dual-regulatory-approvals-for-the-clarity-ii-in-china-and-japan-februar","status":"publish","type":"post","link":"https:\/\/thaipropertynews.com\/feeds\/?p=49504","title":{"rendered":"Cynosure Lutronic bolsters its strength in APAC &#8212; The world&#8217;s fastest-growing medical aesthetics device region, with dual regulatory approvals for the Clarity II\u2122 in China and Japan, February 2026"},"content":{"rendered":"<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2921193\/Cynosure_Lutronic_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span class=\"legendSpanClass\">SINGAPORE<\/span>, <span class=\"legendSpanClass\">Feb. 27, 2026<\/span> \/PRNewswire\/ &#8212;\u00a0Cynosure Lutronic,\u00a0a global leader in energy-based medical aesthetic\u00a0devices, announced\u00a0today\u00a0that Clarity II, its dual-wavelength long-pulse laser platform, has received regulatory approval in China and Japan. This\u00a0marks\u00a0a significant expansion of the company&#8217;s clinically approved laser portfolio across two of Asia&#8217;s most highly regulated aesthetic\u00a0markets.\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnasia.com\/media2\/2921191\/ClarityII_JPCN_RegulatoryPost.html\" target=\"_blank\" rel=\"nofollow\"><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2921191\/ClarityII_JPCN_RegulatoryPost.jpg?p=medium600\" title=\"Clarity II Receives Regulatory Clearance in China and Japan\" alt=\"Clarity II Receives Regulatory Clearance in China and Japan\" \/><\/a><br \/><span>Clarity II Receives Regulatory Clearance in China and Japan<\/span><\/p>\n<\/div>\n<p>&#8220;The approval enables the introduction of a single, integrated dual wavelength laser platform designed to support multiple treatment indications and diverse patient profiles and is also reflective of\u00a0Cynosure Lutronic&#8217;s growing strength across the Asia Pacific region&#8221; said Nadav Tomer, CEO of Cynosure Lutronic.<\/p>\n<p><b><u>China: Regulatory Approval<\/u><\/b>\u00a0<\/p>\n<p>In\u00a0<b>China<\/b>, Clarity II (marketed as\u00a0CLARITY II ICD) has received regulatory approval for use in medical\u00a0institutions\u00a0as of <b>12<sup>th<\/sup>\u00a0February 2026<\/b>.\u00a0\u00a0<\/p>\n<ul type=\"disc\">\n<li><b>Product Name:<\/b>\u00a0Clarity II\u00a0ICD\u00a0<\/li>\n<li><b>Approved Indications:<\/b>\u00a0<\/li>\n<\/ul><ul type=\"disc\">\n<li><b>755nm laser \u2013 approved to reduce wrinkles on the cheeks<\/b>\u00a0<\/li>\n<li><b>1064nm\u00a0laser \u2013 approved to reduce unwanted body\u00a0hair<\/b>\u00a0<\/li>\n<\/ul>\n\n<p>The approval authorizes the use of a single integrated platform across multiple treatment applications within regulated clinical settings\u00a0of\u00a0China.\u00a0<\/p>\n<p><b><u>Japan: Regulatory Approval<\/u><\/b>\u00a0<\/p>\n<p>In\u00a0<b>Japan<\/b>, Clarity II has received regulatory clearance as of\u00a0<b>9<sup>th<\/sup> January 2026<\/b>\u00a0for use in medical aesthetic practices.\u00a0<\/p>\n<ul type=\"disc\">\n<li><b>Product Name:<\/b>\u00a0Clarity II\u00a0<\/li>\n<li><b>Approved Indication:<\/b>\u00a0<\/li>\n<li>Alexandrite 755nm \/\u00a0Nd:YAG\u00a01064nm approved for\u00a0Long-term hair reduction\u00a0<\/li>\n<\/ul>\n<p>The clearance confirms compliance with Japan&#8217;s stringent medical device regulatory requirements for laser-based aesthetic treatments.\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnasia.com\/media2\/2921192\/ClarityII_2.html\" target=\"_blank\" rel=\"nofollow\"><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2921192\/ClarityII_2.jpg?p=medium600\" title=\"ClarityII is a dual-wavelength long-pulse laser system designed to support a range of aesthetic medical applications\" alt=\"ClarityII is a dual-wavelength long-pulse laser system designed to support a range of aesthetic medical applications\" \/><\/a><br \/><span>ClarityII is a dual-wavelength long-pulse laser system designed to support a range of aesthetic medical applications<\/span><\/p>\n<\/div>\n<p><b><u>Clinical and Operational Context<\/u><\/b>\u00a0<\/p>\n<p>In both China and Japan,\u00a0medical\u00a0aesthetic\u00a0practices\u00a0are\u00a0operating\u00a0under increasingly rigorous regulatory and clinical expectations, with heightened emphasis on treatment precision, indication-specific use, and safety.\u00a0<\/p>\n<p>The regulatory approvals of Clarity II reflect growing demand for laser platforms that\u00a0consolidate\u00a0multiple\u00a0clinically validated\u00a0applications within a single system, while\u00a0maintaining\u00a0strict control over energy delivery and treatment parameters. In China, approval across both hair removal and wrinkle treatment applications enables practitioners to address multiple\u00a0patient\u00a0needs\u00a0with\u00a0one versatile platform. In Japan, clearance of the latest-generation system reinforces confidence in technological refinement and output consistency within a highly regulated clinical environment.\u00a0<\/p>\n<p>Together, these approvals position Clarity II as a platform aligned with the evolving standards of advanced aesthetic practice in Asia\u00a0compliance, and clinical versatility are increasingly critical.\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnasia.com\/media2\/2921194\/Clarity_3.html\" target=\"_blank\" rel=\"nofollow\"><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2921194\/Clarity_3.jpg?p=medium600\" title=\"Clarity II delivers precision and efficiency through advanced dual-wavelength technology\" alt=\"Clarity II delivers precision and efficiency through advanced dual-wavelength technology\" \/><\/a><br \/><span>Clarity II delivers precision and efficiency through advanced dual-wavelength technology<\/span><\/p>\n<\/div>\n<p><b><u>About Clarity II<\/u><\/b>\u00a0<\/p>\n<p>Clarity II is a dual-wavelength long-pulse laser system designed to support a range of aesthetic medical applications. The platform integrates:\u00a0<\/p>\n<ul type=\"disc\">\n<li>Alexandrite 755nm and\u00a0Nd:YAG\u00a01064nm wavelengths in a single system\u00a0<\/li>\n<li>Large spot sizes to support efficient treatment of broad areas\u00a0<\/li>\n<li>Short pulse duration capabilities for refined and precision-based treatments\u00a0<\/li>\n<li>A fiber-free system architecture designed to simplify operation and maintenance\u00a0<\/li>\n<li>Automated delivery features intended to support consistency and practitioner workflow\u00a0<\/li>\n<\/ul>\n<p><b><u>About Cynosure\u00a0Lutronic<\/u><\/b>\u00a0<\/p>\n<p>Cynosure\u00a0Lutronic\u00a0was formed following the merger of Cynosure and\u00a0Lutronic\u00a0in 2024\u00a0which\u00a0creates\u00a0a global medical aesthetics organization built on more than 60 years of combined innovation in energy-based technologies.\u00a0<\/p>\n<p>Cynosure\u00a0Lutronic\u00a0develops and commercializes energy-based devices across a wide range of aesthetic indications\u00a0with direct operations in North America, Europe, and Asia-Pacific, and product distribution in approximately 130 countries.\u00a0<\/p>\n<p><a href=\"https:\/\/www.linkedin.com\/company\/cynosure-lutronic-apac\/\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a>\u00a0| <a href=\"https:\/\/www.instagram.com\/cynosure.lutronic.apac\/\" target=\"_blank\" rel=\"nofollow\">Instagram<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<\/div>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<table border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2921193\/Cynosure_Lutronic_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span class=\"legendSpanClass\">SINGAPORE<\/span>, <span class=\"legendSpanClass\">Feb. 27, 2026<\/span> \/PRNewswire\/ &#8212;\u00a0Cynosure Lutronic,\u00a0a global leader in energy-based medical aesthetic\u00a0devices, announced\u00a0today\u00a0that Clarity II, its dual-wavelength long-pulse laser platform, has received regulatory approval in China and Japan. This\u00a0marks\u00a0a significant expansion of the company&#8217;s clinically approved laser portfolio across two of Asia&#8217;s most highly regulated aesthetic\u00a0markets.\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnasia.com\/media2\/2921191\/ClarityII_JPCN_RegulatoryPost.html\" target=\"_blank\" rel=\"nofollow\"><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2921191\/ClarityII_JPCN_RegulatoryPost.jpg?p=medium600\" title=\"Clarity II Receives Regulatory Clearance in China and Japan\" alt=\"Clarity II Receives Regulatory Clearance in China and Japan\" \/><\/a><br \/><span>Clarity II Receives Regulatory Clearance in China and Japan<\/span><\/p>\n<\/div>\n<p>&#8220;The approval enables the introduction of a single, integrated dual wavelength laser platform designed to support multiple treatment indications and diverse patient profiles and is also reflective of\u00a0Cynosure Lutronic&#8217;s growing strength across the Asia Pacific region&#8221; said Nadav Tomer, CEO of Cynosure Lutronic.<\/p>\n<p><b><u>China: Regulatory Approval<\/u><\/b>\u00a0<\/p>\n<p>In\u00a0<b>China<\/b>, Clarity II (marketed as\u00a0CLARITY II ICD) has received regulatory approval for use in medical\u00a0institutions\u00a0as of <b>12<sup>th<\/sup>\u00a0February 2026<\/b>.\u00a0\u00a0<\/p>\n<ul type=\"disc\">\n<li><b>Product Name:<\/b>\u00a0Clarity II\u00a0ICD\u00a0<\/li>\n<li><b>Approved Indications:<\/b>\u00a0<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li><b>755nm laser \u2013 approved to reduce wrinkles on the cheeks<\/b>\u00a0<\/li>\n<li><b>1064nm\u00a0laser \u2013 approved to reduce unwanted body\u00a0hair<\/b>\u00a0<\/li>\n<\/ul>\n<p>The approval authorizes the use of a single integrated platform across multiple treatment applications within regulated clinical settings\u00a0of\u00a0China.\u00a0<\/p>\n<p><b><u>Japan: Regulatory Approval<\/u><\/b>\u00a0<\/p>\n<p>In\u00a0<b>Japan<\/b>, Clarity II has received regulatory clearance as of\u00a0<b>9<sup>th<\/sup> January 2026<\/b>\u00a0for use in medical aesthetic practices.\u00a0<\/p>\n<ul type=\"disc\">\n<li><b>Product Name:<\/b>\u00a0Clarity II\u00a0<\/li>\n<li><b>Approved Indication:<\/b>\u00a0<\/li>\n<li>Alexandrite 755nm \/\u00a0Nd:YAG\u00a01064nm approved for\u00a0Long-term hair reduction\u00a0<\/li>\n<\/ul>\n<p>The clearance confirms compliance with Japan&#8217;s stringent medical device regulatory requirements for laser-based aesthetic treatments.\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnasia.com\/media2\/2921192\/ClarityII_2.html\" target=\"_blank\" rel=\"nofollow\"><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2921192\/ClarityII_2.jpg?p=medium600\" title=\"ClarityII is a dual-wavelength long-pulse laser system designed to support a range of aesthetic medical applications\" alt=\"ClarityII is a dual-wavelength long-pulse laser system designed to support a range of aesthetic medical applications\" \/><\/a><br \/><span>ClarityII is a dual-wavelength long-pulse laser system designed to support a range of aesthetic medical applications<\/span><\/p>\n<\/div>\n<p><b><u>Clinical and Operational Context<\/u><\/b>\u00a0<\/p>\n<p>In both China and Japan,\u00a0medical\u00a0aesthetic\u00a0practices\u00a0are\u00a0operating\u00a0under increasingly rigorous regulatory and clinical expectations, with heightened emphasis on treatment precision, indication-specific use, and safety.\u00a0<\/p>\n<p>The regulatory approvals of Clarity II reflect growing demand for laser platforms that\u00a0consolidate\u00a0multiple\u00a0clinically validated\u00a0applications within a single system, while\u00a0maintaining\u00a0strict control over energy delivery and treatment parameters. In China, approval across both hair removal and wrinkle treatment applications enables practitioners to address multiple\u00a0patient\u00a0needs\u00a0with\u00a0one versatile platform. In Japan, clearance of the latest-generation system reinforces confidence in technological refinement and output consistency within a highly regulated clinical environment.\u00a0<\/p>\n<p>Together, these approvals position Clarity II as a platform aligned with the evolving standards of advanced aesthetic practice in Asia\u00a0compliance, and clinical versatility are increasingly critical.\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p><a href=\"https:\/\/mma.prnasia.com\/media2\/2921194\/Clarity_3.html\" target=\"_blank\" rel=\"nofollow\"><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2921194\/Clarity_3.jpg?p=medium600\" title=\"Clarity II delivers precision and efficiency through advanced dual-wavelength technology\" alt=\"Clarity II delivers precision and efficiency through advanced dual-wavelength technology\" \/><\/a><br \/><span>Clarity II delivers precision and efficiency through advanced dual-wavelength technology<\/span><\/p>\n<\/div>\n<p><b><u>About Clarity II<\/u><\/b>\u00a0<\/p>\n<p>Clarity II is a dual-wavelength long-pulse laser system designed to support a range of aesthetic medical applications. The platform integrates:\u00a0<\/p>\n<ul type=\"disc\">\n<li>Alexandrite 755nm and\u00a0Nd:YAG\u00a01064nm wavelengths in a single system\u00a0<\/li>\n<li>Large spot sizes to support efficient treatment of broad areas\u00a0<\/li>\n<li>Short pulse duration capabilities for refined and precision-based treatments\u00a0<\/li>\n<li>A fiber-free system architecture designed to simplify operation and maintenance\u00a0<\/li>\n<li>Automated delivery features intended to support consistency and practitioner workflow\u00a0<\/li>\n<\/ul>\n<p><b><u>About Cynosure\u00a0Lutronic<\/u><\/b>\u00a0<\/p>\n<p>Cynosure\u00a0Lutronic\u00a0was formed following the merger of Cynosure and\u00a0Lutronic\u00a0in 2024\u00a0which\u00a0creates\u00a0a global medical aesthetics organization built on more than 60 years of combined innovation in energy-based technologies.\u00a0<\/p>\n<p>Cynosure\u00a0Lutronic\u00a0develops and commercializes energy-based devices across a wide range of aesthetic indications\u00a0with direct operations in North America, Europe, and Asia-Pacific, and product distribution in approximately 130 countries.\u00a0<\/p>\n<p><a href=\"https:\/\/www.linkedin.com\/company\/cynosure-lutronic-apac\/\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a>\u00a0| <a href=\"https:\/\/www.instagram.com\/cynosure.lutronic.apac\/\" target=\"_blank\" rel=\"nofollow\">Instagram<\/a><\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<\/div>\n<p><!-- \/wp:html --><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":[],"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[1],"tags":[],"class_list":["post-49504","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/49504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=49504"}],"version-history":[{"count":0,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=\/wp\/v2\/posts\/49504\/revisions"}],"wp:attachment":[{"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=49504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=49504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thaipropertynews.com\/feeds\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=49504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}